Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services

Go back to Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services

Quest Diagnostics (DGX) PT Raised to $96 at Jefferies Following 4Q Earnings Report

January 27, 2017 9:03 AM EST

Jefferies raised its price target on Quest Diagnostics (NYSE: DGX) to $96.00 (from $86.00) while maintaining a Hold rating. DGX posted its 5th consecutive quarter of positive organic volume growth, which yielded a $0.04/3% EPS beat on in-line EBITDA.

Analyst Brian Tanquilut commented, "We... More